Clinical Outcomes of Subretinal AGTC-501 in X-linked Retinitis Pigmentosa
The following is a summary of “Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2...
Read MoreDec 9, 2024
The following is a summary of “Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2...
Read MoreNov 12, 2024
The presence of both the interdigitation & ellipsoid zones was found to be associated with better visual acuity in patients with retinitis pigmentosa.
Read MoreApr 17, 2024
Cataract surgery appears to be beneficial for retinitis pigmentosa and cataract, with similar rates of intraoperative complications compared with control eyes.
Read MoreMar 3, 2024
Cataract surgery improves vision in retinitis pigmentosa eyes, yet poses a higher risk of postoperative cystoid macular edema compared to nonaffected eyes.
Read MoreMar 2, 2024
MRDQ domains strongly correlate with visual function in retinitis pigmentosa, validating their use in assessing quality of life.
Read MoreApr 3, 2023
Retinitis pigmentosa (RP) is a group of devastating inherited retinal diseases that leads to...
Read MoreNov 15, 2021
A method of evaluating central visual field (VF) progression in eyes with retinitis pigmentosa...
Read MoreOct 10, 2021
Interim safety and clinical activity data from the Phase 1/2 clinical trial of intravitreal 4D-125 in patients with advanced X-linked retinitis pigmentosa (XLRP) was presented in a late-breaking presentation at the American...
Read MoreAug 19, 2021
AimTo describe the clinical presentation and demographic distribution of retinitis pigmentosa in...
Read MoreJul 12, 2021
The purpose of this study was to detect the presence of retinitis pigmentosa (RP) based on color...
Read MoreJan 18, 2021
The current methods used to assess visual function in blind retinitis pigmentosa (RP) patients are...
Read MoreDec 31, 2020
The purpose of this study was to perform a detailed longitudinal phenotyping of X-linked retinitis...
Read MoreDec 3, 2020
X-linked retinitis pigmentosa (XLRP) accounts for a significant proportion of certifiable...
Read MoreOct 15, 2020
Retinitis pigmentosa (RP) is a collection of heterogenous genetic retinal disorders resulting in...
Read MoreOct 12, 2020
Transcorneal electrical stimulation (TES) is a novel treatment approach for patients with...
Read MoreOct 8, 2020
The cause of autosomal-dominant retinitis pigmentosa (adRP), which leads to loss of vision and...
Read MoreOct 1, 2020
Retinitis pigmentosa (RP) is the most common cause of inherited blindness and is characterised by...
Read MoreSep 14, 2020
: In retinitis pigmentosa (RP), inherited rod death is followed by cone loss and blindness. Why...
Read MoreJun 22, 2020
Primary angle-closure glaucoma (PACG) and retinitis pigmentosa (RP) can co-occur, but the...
Read MoreApr 8, 2024
Female carriers of choroideremia and X-linked retinitis pigmentosa have significantly worse visual symptoms across seven domains compared with healthy patients.
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.